Absence of the Susceptibility Vessel Sign with Cancer-Associated Hypercoagulability-Related Stroke

References

1. 1.↵
   1. Navi BB,
   2. Iadecola C

   . Ischemic stroke in cancer patients: a review of an underappreciated pathology. Ann Neurol 2018;83:873–83 doi:10.1002/ana.25227 pmid:29633334

   CrossRefPubMed
2. 2.↵
   1. Navi BB,
   2. Reiner AS,
   3. Kamel H, et al

   . Risk of arterial thromboembolism in patients with cancer. J Am Coll Cardiol 2017;70:926–38 doi:10.1016/j.jacc.2017.06.047 pmid:28818202

   FREE Full Text
3. 3.↵
   1. Navi BB,
   2. Reiner AS,
   3. Kamel H, et al

   . Association between incident cancer and subsequent stroke. Ann Neurol 2015;77:291–300 doi:10.1002/ana.24325 pmid:25472885

   CrossRefPubMed
4. 4.↵
   1. Bang OY,
   2. Chung JW,
   3. Lee MJ, et al

   ; OASIS-Cancer Study Investigators. Cancer-related stroke: an emerging subtype of ischemic stroke with unique pathomechanisms. J Stroke 2020;22:1–10 doi:10.5853/jos.2019.02278 pmid:32027788

   CrossRefPubMed
5. 5.↵
   1. Kim SG,
   2. Hong JM,
   3. Kim HY, et al

   . Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Stroke 2010;41:798–801 doi:10.1161/STROKEAHA.109.571356 pmid:20150545

   Abstract/FREE Full Text
6. 6.↵
   1. Kwon HM,
   2. Kang BS,
   3. Yoon BW

   . Stroke as the first manifestation of concealed cancer. J Neurol Sci 2007;258:80–83 doi:10.1016/j.jns.2007.02.035 pmid:17408695

   CrossRefPubMed
7. 7.↵
   1. Pan KH,
   2. Kim J,
   3. Chung JW, et al

   . Significance of D-dimer in acute ischemic stroke patients with large vessel occlusion accompanied by active cancer. Front Neurol 2022;13:843871 doi:10.3389/fneur.2022.843871 pmid:35401408

   CrossRefPubMed
8. 8.↵
   1. Matsumoto N,
   2. Fukuda H,
   3. Handa A, et al

   . Histological examination of Trousseau syndrome-related thrombus retrieved through acute endovascular thrombectomy: report of 2 cases. J Stroke Cerebrovasc Dis 2016;25:e227–30 doi:10.1016/j.jstrokecerebrovasdis.2016.08.041 pmid:27720526

   CrossRefPubMed
9. 9.↵
   1. Lee D,
   2. Lee DH,
   3. Suh DC, et al

   . Intra-arterial thrombectomy for acute ischaemic stroke patients with active cancer. J Neurol 2019;266:2286–93 doi:10.1007/s00415-019-09416-8 pmid:31175434

   CrossRefPubMed
10. 10.↵
    1. Jang H,
    2. Lee JJ,
    3. Lee MJ, et al

    . Comparison of enoxaparin and warfarin for secondary prevention of cancer-associated stroke. J Oncol 2015;2015:502089 doi:10.1155/2015/502089 pmid:26064116

    CrossRefPubMed
11. 11.↵
    1. Cho KH,
    2. Kim JS,
    3. Kwon SU, et al

    . Significance of susceptibility vessel sign on T2*-weighted gradient echo imaging for identification of stroke subtypes. Stroke 2005;36:2379–83 doi:10.1161/01.STR.0000185932.73486.7a pmid:16224077

    Abstract/FREE Full Text
12. 12.↵
    1. Bourcier R,
    2. Derraz I,
    3. Delasalle B, et al

    ; THRACE Investigators. Susceptibility vessel sign and cardioembolic etiology in the THRACE trial. Clin Neuroradiol 2019;29:685–92 doi:10.1007/s00062-018-0699-8 pmid:29947813

    CrossRefPubMed
13. 13.↵
    1. Liu M,
    2. Li L,
    3. Li G

    . The different clinical value of susceptibility vessel sign in acute ischemic stroke patients under different interventional therapy: a systematic review and meta-analysis. J Clin Neurosci 2019;62:72–79 doi:10.1016/j.jocn.2019.01.002 pmid:30712778

    CrossRefPubMed
14. 14.↵
    1. Kim SK,
    2. Yoon W,
    3. Kim TS, et al

    . Histologic analysis of retrieved clots in acute ischemic stroke: correlation with stroke etiology and gradient-echo MRI. AJNR Am J Neuroradiol 2015;36:1756–62 doi:10.3174/ajnr.A4402 pmid:26159515

    Abstract/FREE Full Text
15. 15.↵
    1. Dillmann M,
    2. Bonnet L,
    3. Vuillier F, et al

    . Factors that influence susceptibility vessel sign in patients with acute stroke referred for mechanical thrombectomy. Front Neurol 2022;13:893060 doi:10.3389/fneur.2022.893060 pmid:35645960

    CrossRefPubMed
16. 16.↵
    1. Okada S,
    2. Miyagawa-Hayashino A,
    3. Fujinami J, et al

    . Trousseau’s syndrome associated with pulmonary pleomorphic carcinoma exhibiting aggressive features: a case report. Mol Clin Oncol 2020;12:36–40 doi:10.3892/mco.2019.1947 pmid:31814975

    CrossRefPubMed
17. 17.↵
    1. Kuroda N,
    2. Hiramatsu H,
    3. Mori M, et al

    . Mechanical thrombectomy for Trousseau syndrome in a terminally ill cancer patient. J Pain Symptom Manage 2019;57:688–94 doi:10.1016/j.jpainsymman.2018.12.327 pmid:30576713

    CrossRefPubMed
18. 18.↵
    1. Maezono-Kandori K,
    2. Ohara T,
    3. Fujinami J, et al

    . Elevated CA125 is related to stroke due to cancer-associated hypercoagulation. J Stroke Cerebrovasc Dis 2021;30:106126 doi:10.1016/j.jstrokecerebrovasdis.2021.106126 pmid:34592610

    CrossRefPubMed
19. 19.↵
    1. Adams HP,
    2. Bendixen BH,
    3. Kappelle L, et al

    . Classification of subtype of acute ischemic stroke definitions for use in a multicenter clinical trial. Stroke 1993;24:35–41 doi:10.1161/01.str.24.1.35 pmid:7678184

    Abstract/FREE Full Text
20. 20.↵
    1. Beyeler M,
    2. Belachew NF,
    3. Kielkopf M, et al

    . Absence of susceptibility vessel sign in patients with malignancy-related acute ischemic stroke treated with mechanical thrombectomy. Front Neurol 2022;13:930635 doi:10.3389/fneur.2022.930635 pmid:35911907

    CrossRefPubMed
21. 21.↵
    1. Finelli PF,
    2. Nouh A

    . Three-territory DWI acute infarcts: diagnostic value in cancer-associated hypercoagulation stroke (Trousseau syndrome). AJNR Am J Neuroradiol 2016;37:2033–36 doi:10.3174/ajnr.A4846 pmid:27365322

    Abstract/FREE Full Text
22. 22.↵
    1. Rovira A,
    2. Orellana P,
    3. Alvarez-Sabín J, et al

    . Hyperacute ischemic stroke: middle cerebral artery susceptibility sign at echo-planar gradient-echo MR imaging. Radiology 2004;232:466–73 doi:10.1148/radiol.2322030273 pmid:15215546

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Liebeskind DS,
    2. Sanossian N,
    3. Yong WH, et al

    . CT and MRI early vessel signs reflect clot composition in acute stroke. Stroke 2011;42:1237–43 doi:10.1161/STROKEAHA.110.605576 pmid:21393591

    Abstract/FREE Full Text
24. 24.↵
    1. Sato Y,
    2. Ishibashi-Ueda H,
    3. Iwakiri T, et al

    . Thrombus components in cardioembolic and atherothrombotic strokes. Thromb Res 2012;130:278–80 doi:10.1016/j.thromres.2012.04.008 pmid:22542364

    CrossRefPubMed
25. 25.↵
    1. Ogata J,
    2. Yutani C,
    3. Otsubo R, et al

    . Heart and vessel pathology underlying brain infarction in 142 stroke patients. Ann Neurol 2008;63:770–81 doi:10.1002/ana.21401 pmid:18496843

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Park H,
    2. Kim J,
    3. Ha J, et al

    . Histological features of intracranial thrombi in stroke patients with cancer. Ann Neurol 2019;86:143–49 doi:10.1002/ana.25495 pmid:31025392

    CrossRefPubMed
27. 27.↵
    1. Fu CH,
    2. Chen CH,
    3. Lin YH, et al

    . Fibrin and platelet-rich composition in retrieved thrombi hallmarks stroke with active cancer. Stroke 2020;51:3723–27 doi:10.1161/STROKEAHA.120.032069 pmid:33138690

    CrossRefPubMed
28. 28.↵
    1. Varki A

    . Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood 2007;110:1723–29 doi:10.1182/blood-2006-10-053736 pmid:17496204

    Abstract/FREE Full Text
29. 29.↵
    1. Hart RG,
    2. Diener HC,
    3. Coutts SB, et al

    . Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol 2014;13:429–38 doi:10.1016/S1474-4422(13)70310-7 pmid:24646875

    CrossRefPubMed